Brief: Tristel Confirms Submission Of Additional Information To FDA For Tristel OPH
April 10 (Reuters) - Tristel PLC TSTL.L: TRISTEL PLC - ADDITIONAL INFO. SUBMITTED TO FDA FOR TRISTEL OPH TRISTEL PLC - CONFIRMS SUBMITTED ADDITIONAL INFORMATION TO FDA FOR TRISTEL OPH TRISTEL PLC - EXPECTS FDA DECISION BY END OF JUNE 2025 Source text: ID:nRSJ4027Ea Further company coverage: TSTL.L ((Reuters.Briefs@thomsonreuters.com))